Circulating Tumor Cells as the Liquid Biopsy Foray into Noninvasive Colorectal Cancer Screening.
Circulating tumor cells detected through blood tests show promise as a noninvasive way to screen for colorectal cancer earlier than current methods allow.
This article evaluates circulating tumor cells as a liquid biopsy approach to noninvasive colorectal cancer screening, a field dominated by ctDNA methods. It frames CTC technology as having distinct advantages for early detection and proposes a pathway toward clinical validation.
What the study was
- Study design
- Perspective/commentary with clinical framework
- Population
- Colorectal cancer screening population
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Cancer Epidemiology, Biomarkers & Prevention
Why it surfaced
CTC-based liquid biopsy for CRC screening is a novel angle in the early detection space. Published in CEBP (high impact), directly addresses a major watchlist area.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.